Evidence map›Paper›PMID 37103092›Full record

ArticleIn vivo (Athens, Greece)

Toru Ishikawa, Iori Hasegawa, Hiroshi Hirosawa, Tsubasa Honmou, Nobuyuki Sakai, Takanori Igarashi, Shun Yamazaki, Takamasa Kobayashi, Toshifumi Sato, Akito Iwanaga and 3 more

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Toru IshikawaDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan; toruishi@ngt.saiseikai.or.jp.
Iori HasegawaDepartment of Clinical Engineering, Saiseikai Niigata Hospital, Niigata, Japan.
Hiroshi HirosawaDepartment of Clinical Engineering, Saiseikai Niigata Hospital, Niigata, Japan.
Tsubasa HonmouDepartment of Clinical Engineering, Saiseikai Niigata Hospital, Niigata, Japan.
Nobuyuki SakaiDepartment of Clinical Engineering, Saiseikai Niigata Hospital, Niigata, Japan.
Takanori IgarashiDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Shun YamazakiDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Takamasa KobayashiDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Toshifumi SatoDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Akito IwanagaDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Tomoe SanoDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Junji YokoyamaDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Terasu HonmaDepartment of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Saiseikai Niigata Daini Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimAblating a spherical area during hepatocellular carcinoma ablation therapy is a very important issue. We aimed to determine the ablation area of bovine liver using various radiofrequency ablation (RFA) protocols. MATERIALS AND

methodsBovine liver (1-2 kg) was placed in an aluminum tray, which was punctured with STARmed VIVA 2.0 17-gauge (G) and 15-G electrodes using a current-carrying tip. Under the step-up or linear method, with an ablation time up to one break and RFA output stop, the size of the color change area (representing the thermally coagulated area) of the bovine liver was measured along the vertical and horizontal axes, and the ablated volume and total heat generated were calculated.

results5-W per minute increases protocol resulted in greater horizontal and vertical diameters of the ablated area than 10-W per minute increases protocol under the step-up method. For 5-W and 10-W per minute increases under the step-up method, the aspect ratio was 0.81 and 0.67 with a 17-G electrode, and 0.73 and 0.69 with a 15-G electrode, respectively. For 5-W and 10-W increases under the linear method, the aspect ratio was 0.89 and 0.82, respectively. Sufficient ablation was obtained, with vertical and horizontal diameters of 50 mm and 43.50 mm, respectively. Although the ablation time was long, the watt output value at the break and average watt value were low.

conclusionGradual increase in output (5 W) using the step-up method yielded a more spherical ablation area, and longer ablation time in the linear method with a 15-G electrode could result in a more spherical ablation area in real clinical practice in humans. Future studies should examine concerns regarding long ablation times.

Indexed as

Catheter AblationRadiofrequency AblationAnimalsCattleElectrodesHumansLiverTime Factors15 gaugeAblation arealinear moderadiofrequency ablation

Identifiers

PMID37103092
PMCPMC10187999
OpenAlexW4367175110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.